David Cullinane (Waterford, Sinn Fein) | Oireachtas source

I was just looking for clarity on that. The committee will have to study the recommendations or report that will come from the EMA but given that it seems to be very similar to the AstraZeneca vaccine in its warning and authorised use for all people over 18, with the benefits outweighing the risk, is it possible we will see a similar recommendation coming from NIAC on the Johnson & Johnson vaccine that we have with AstraZeneca? It seems to be exactly the same position. There is a warning but the EMA is saying that it is suitable for everybody over 18. Will we be looking at a similar recommendation for the Johnson & Johnson vaccine?